» Articles » PMID: 14524706

Altered Glucose Transport and Shikimate Pathway Product Yields in E. Coli

Overview
Journal Biotechnol Prog
Date 2003 Oct 4
PMID 14524706
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Different glucose transport systems are examined for their impact on phosphoenolpyruvate availability as reflected by the yields of 3-dehydroshikimic acid and byproducts 3-deoxy-d-arabino-heptulosonic acid, 3-dehydroquinic acid, and gallic acid synthesized by Escherichia coli from glucose. 3-Dehydroshikimic acid is an advanced shikimate pathway intermediate in the syntheses of a spectrum of commodity, pseudocommodity, and fine chemicals. All constructs carried plasmid aroF(FBR) and tktA inserts encoding, respectively, a feedback-insensitive isozyme of 3-deoxy-d-arabino-heptulosonic acid 7-phosphate synthase and transketolase. Reliance on the native E. coli phosphoenolpyruvate:carbohydrate phosphotransferase system for glucose transport led in 48 h to the synthesis of 3-dehydroshikimic acid (49 g/L) and shikimate pathway byproducts in a total yield of 33% (mol/mol). Use of heterologously expressed Zymomonas mobilis glf-encoded glucose facilitator and glk-encoded glucokinase resulted in the synthesis in 48 h of 3-dehydroshikimic acid (60 g/L) and shikimate pathway byproducts in a total yield of 41% (mol/mol). Recruitment of native E. coli galP-encoded galactose permease for glucose transport required 60 h to synthesize 3-dehydroshikimic acid (60 g/L) and shikimate pathway byproducts in a total yield of 43% (mol/mol). Direct comparison of the impact of altered glucose transport on the yields of shikimate pathway products synthesized by E. coli has been previously hampered by different experimental designs and culturing conditions. In this study, the same product and byproduct mixture synthesized by E. coli constructs derived from the same progenitor strain is used to compare strategies for increasing phosphoenolpyruvate availability. Constructs are cultured under the same set of fermentor-controlled conditions.

Citing Articles

Aromatic Amino Acids: Exploring Microalgae as a Potential Biofactory.

Niraula A, Danesh A, Merindol N, Meddeb-Mouelhi F, Desgagne-Penix I BioTech (Basel). 2025; 14(1).

PMID: 39982273 PMC: 11843938. DOI: 10.3390/biotech14010006.


Engineered Passive Glucose Uptake in Pseudomonas taiwanensis VLB120 Increases Resource Efficiency for Bioproduction.

Schwanemann T, Krink N, Nikel P, Wynands B, Wierckx N Microb Biotechnol. 2025; 18(1):e70095.

PMID: 39871105 PMC: 11772102. DOI: 10.1111/1751-7915.70095.


Chromosome Engineering To Generate Plasmid-Free Phenylalanine- and Tyrosine-Overproducing Strains That Can Be Applied in the Generation of Aromatic-Compound-Producing Bacteria.

Koma D, Kishida T, Yoshida E, Ohashi H, Yamanaka H, Moriyoshi K Appl Environ Microbiol. 2020; 86(14).

PMID: 32414798 PMC: 7357484. DOI: 10.1128/AEM.00525-20.


Bioprocess Optimization for the Production of Aromatic Compounds With Metabolically Engineered Hosts: Recent Developments and Future Challenges.

Braga A, Faria N Front Bioeng Biotechnol. 2020; 8:96.

PMID: 32154231 PMC: 7044121. DOI: 10.3389/fbioe.2020.00096.


Parallel experimental evolution reveals a novel repressive control of GalP on xylose fermentation in Escherichia coli.

Kurgan G, Sievert C, Flores A, Schneider A, Billings T, Panyon L Biotechnol Bioeng. 2019; 116(8):2074-2086.

PMID: 31038200 PMC: 11161036. DOI: 10.1002/bit.27004.